期刊文献+

关节置换术后感染的治疗 被引量:1

Treatment of infection after joint replacement
下载PDF
导出
摘要 膝和髋关节置换术后2年内感染风险最高。感染的主要致病菌为G+球菌,以金黄色葡萄球菌、表皮葡萄球菌最常见;诊断时应正确获取标本,关注ESR、CRP、影像学等实验室指标;临床治疗时常用二期假体置换术并用抗生素治疗6。8周:在抗生素治疗过程中,临床药师发挥专业优势,根据患者的年龄、肝肾功能、感染的致病茵选择合理的抗生素,为患者提供个体化的治疗方案,并在患者出院时做好用药教育,提高患者用药的依从性,从而取得良好的治疗效果。 The highest infection risk in knee and hip replacement surgery occur within two years. The main pathogenic bacterium of infection is G+ cocci including staphylococcus aureus, staphylococcus epidermidis. It is important to obtain proper specimens and monitor ESR, CRP, iconography and other laboratory parameters. The common treatment is the second stage of revision with infection of prosthetic replacement and combination with antibiotic therapy for 6-8 weeks. Clinical pharmacists exert preponderance during antibiotic therapy. They select the proper antibiotic for patients and design individualized treatment programs according to the age, renal function and pathogen of the patients. They also provide pharmaceutical service when patients discharge from the hospital, which improves compliance of drug use and obtains good therapeutic effect.
出处 《中国药物应用与监测》 CAS 2011年第5期284-285,共2页 Chinese Journal of Drug Application and Monitoring
关键词 关节置换术 感染 临床药师 Joint replacement Infection Clinical pharmacist
  • 相关文献

参考文献10

二级参考文献144

共引文献118

同被引文献17

  • 1王珏,马珊,常青.万古霉素对老年患者肾毒性的观察及血药浓度监测的意义[J].中国基层医药,2006,13(12):1984-1986. 被引量:12
  • 2汤晟凌,周慧萍,刘云,王丽娟.万古霉素不良反应报道文献分析[J].中国药业,2007,16(16):51-52. 被引量:19
  • 3Amy Schilling, Elizabeth Neuner, Susan J. Rehm. Vancomycin: A 50- something-year-old antibiotic we still don't understand[J]. Cleveland Clinic Journal of Medicine,2011,78(7) :465 -471.
  • 4Catherine Liu, Arnold Bayer, Sara E. Cosgrove, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America for the in Treat- ment of Methicillin-Resistant Staphylococcus aureus Infections Adults and Children : Executive Summary [ J ]. MRSA Treatment Guidelines, 2011, 52 (1 February) :285 - 292.
  • 5Jennifer H Martin, Ross Norris, Michael Barras, et al. Therapeutic Monitor- ing of Vancomycin in Adult Patients : A Consensus Review of the American Society of Health - System Pharmac - ists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharm - acists I J]. Clin Biochem Rev,2010,31:21 -24.
  • 6Finchl RG, Eliopoulos GM. Safety and efficacy of glycopeptide antibi- otics [ J ]. Journal of Antimicrobial Chemotherapy, 2005,55 ( Suppl S2 ) : ii5- ii13.
  • 7Taggart T, Kerry RM, Norman P, et al. The use of vancomycin - impregnated cement beads in the management of infection of prosthetic joints [J ]. J Bone Joint Surg [ Br], 2002,84 - B : 70 - 72.
  • 8鱼爱和,聂昭华,孙光.万古霉素相关的致肾衰危险因素与预防[J].中国药师,2008,11(10):1253-1254. 被引量:10
  • 9仲伟潭,赵宏阳,魏增辉,周站云.糖肽类抗耐药菌抗生素的研究进展[J].河北化工,2009,32(6):22-24. 被引量:9
  • 10姚勤红,徐蕾,窦文琴,陈志高.万古霉素临床应用的合理性分析[J].药学与临床研究,2009,17(4):334-337. 被引量:3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部